Intravenous thrombolytic therapy for acute ischemic stroke - Weighing the risks and benefits of tissue plasminogen activator

被引：5
|
作者：
Koller, RL
Anderson, DC
机构：
[1] Koller Clin Neurol, Bend, OR 97701 USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
来源：
POSTGRADUATE MEDICINE | 1998年 / 103卷 / 04期
关键词：
D O I：
10.3810/pgm.1998.04.457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The use of intravenous tPA within 3 hours after acute ischemic stroke has been proved to increase the number of good outcomes. However, tPA is a toxic therapy that carries a substantial risk of intracerebral hemorrhage. To decrease the risk, tPA use must be restricted to a carefully selected patient population. Treatment must be administered in an intensive care setting and directed by physicians with expertise in diagnosing and managing stroke.
引用
收藏
页码：221 / +
页数：7
相关论文
共 50 条
  • [41] Role of Tissue Plasminogen Activator in Acute Ischemic Stroke
    Hatcher, Molly A.
    Starr, Jessica A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 364 - 371
  • [42] Role of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke with Large Vessel Occlusion
    Ooi, Yinn Cher
    Miremadi, Brian Behdad
    Mukarram, Faisal
    Kaneko, Naoki
    Nour, May
    Colby, Geoffrey
    Jahan, Reza
    Tateshima, Satoshi
    Duckwiler, Gary
    Saver, Jeffrey
    Szeder, Viktor
    [J]. WORLD NEUROSURGERY, 2021, 148 : E321 - E325
  • [43] Tissue plasminogen activator for acute ischemic stroke - Reply
    Kwiatkowski, TK
    Libman, RB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16): : 1240 - 1241
  • [44] Intravenous Tissue Plasminogen Activator in Patients With Cocaine-Associated Acute Ischemic Stroke
    Martin-Schild, Sheryl
    Albright, Karen C.
    Misra, Vivek
    Philip, Maria
    Barreto, Andrew D.
    Hallevi, Hen
    Grotta, James C.
    Savitz, Sean I.
    [J]. STROKE, 2009, 40 (11) : 3635 - 3637
  • [45] Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Broderick, J
    Lu, M
    Jackson, C
    Pancioli, A
    Tilley, BC
    Fagan, SC
    Kothari, R
    Levine, SR
    Marler, JR
    Lyden, PD
    Haley, EC
    Brott, T
    Grotta, JC
    [J]. ANNALS OF NEUROLOGY, 2001, 49 (06) : 736 - 744
  • [46] Safety and Feasibility of Intravenous Tissue Plasminogen Activator (IV-tPA) in Acute Ischemic Stroke Patients, Update on Tabriz Thrombolytic Therapy on Acute Ischemic Stroke (T3AIS) Project
    Hokmabadi, Sadeghi E.
    Farhoudi, M.
    Oskouei, Savadi D.
    Taheraghdam, A.
    Hashemilar, M.
    Yazdchi, M.
    Mehrvar, K.
    Ghiasi, Rikhtegar R.
    Hassasi, R.
    Farzi, M. A.
    Aliyar, H.
    Mehdizadeh, E.
    Tamar, Hasaneh S.
    Hadavibavili, M.
    [J]. CEREBROVASCULAR DISEASES, 2016, 42 : 46 - 46
  • [47] Intravenous Tissue Plasminogen Activator Therapy for an Acute Ischemic Stroke Patient with Later Diagnosed Unilateral Moyamoya Syndrome
    Yokoyama, Shota
    Manabe, Yasuhiro
    Fujii, Daiki
    Ikeda-Sakai, Yasuko
    Narai, Hisashi
    Omori, Nobuhiko
    Abe, Koji
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07): : 1190 - 1192
  • [48] Microbleeds and intravenous thrombolytic therapy in acute ischemic stroke
    Boulanger, JM
    Demchuk, AM
    Buchan, AM
    Coutts, SB
    Simon, JE
    [J]. NEUROLOGY, 2005, 64 (06) : A213 - A213
  • [49] Intravenous thrombolytic therapy in acute ischemic stroke in Taiwan
    Chang, KC
    Wong, WJ
    Lein, LM
    Ann, MY
    Jong, GP
    Kuo, TH
    Liou, CW
    Hu, HH
    [J]. STROKE, 2000, 31 (11) : 2835 - 2835
  • [50] Intravenous Thrombolytic Therapy for Acute Ischemic Stroke REPLY
    Wechsler, Lawrence R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10): : 966 - 967
12345